Healthcare in United Kingdom Insights

Image related to an article about HUTCHMED (China)

Are analysts upbeat on the outlook for HUTCHMED (China)?

Healthcare

While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as HUTCHMED (China) (LON:HCM).  HUTCHME...

LON:HCM

Image related to an article about AstraZeneca

Are analysts upbeat on the outlook for AstraZeneca?

Healthcare

While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as AstraZeneca (LON:AZN).  AstraZeneca...

LON:AZN

Image related to an article about Indivior

Why Indivior is a market favourite

Healthcare

Some shares have withstood recent economic shockwaves better than others - but is Indivior (LON:INDV) one of them? To understand why different shares respond to chaos in different ways, it pays to look at their strengths. In bull marke...

LON:INDV

Image related to an article about Abcam

Are analysts upbeat on the outlook for Abcam?

Healthcare

While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the country's largest quoted companies, such as Abcam (LON:ABC).  Abcam is an import...

LON:ABC

Image related to an article about ConvaTec

What lies in store for the ConvaTec share price?

Healthcare

Economic uncertainty remains a major concern in many industry sectors. For investors in well known companies like ConvaTec (LON:CTEC), the question is: where will prices go from here? ConvaTec is part of an elite club of UK shares whic...

LON:CTEC

Image related to an article about Inspecs

Here is how city analysts rate Inspecs

Healthcare

When it comes to researching shares, many investors take note of what city analysts have to say. The trading recommendations of these professionals are used by everyone from institutional fund managers to individual private investors....

LON:SPEC

Image related to an article about Futura Medical

Will the Futura Medical share price run continue?

Healthcare

In this article we will quickly re-cap the broker forecasts for Futura Medical (LON:FUM). The Futura Medical share price has risen by 6.45% over the past month and it’s currently trading at 30.1p. For investors considering whether to b...

LON:FUM

Image related to an article about Omega Diagnostics

How do brokers rate Omega Diagnostics?

Healthcare

Broker recommendations can be a useful indicator when it comes to researching shares. Examining the average (sometimes called the 'consensus') rating among analysts can offer a guide to whether a share is worth buying or not.  Take Ome...

LON:ODX

Image related to an article about Deltex Medical

What is the broker consensus view on Deltex Medical?

Healthcare

'Buy' and 'sell' recommendations from company analysts often catch the attention of investors - but it's worth remembering that city experts can get things wrong. So rather than relying on just one recommendation, a potentially better...

LON:DEMG

Image related to an article about Hikma Pharmaceuticals

Is the Hikma Pharmaceuticals share price too low?

Healthcare

Good shares at cheap prices are what the very best investors look for. At this time of economic turmoil, could Hikma Pharmaceuticals (LON:HIK) be one of them? When it comes to the proven drivers of stock market profits, "good" and "che...

LON:HIK

Image related to an article about Renalytix

The Renalytix share price – where next?

Healthcare

The Renalytix (LON:RENX) share price has risen by 6.25% over the past month and it’s currently trading at 170p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue....

LON:RENX

Image related to an article about AstraZeneca

What lies in store for the AstraZeneca share price?

Healthcare

Economic uncertainty remains a major concern in many industry sectors. For investors in well known companies like AstraZeneca (LON:AZN), the question is: where will prices go from here? AstraZeneca is part of an elite club of UK shares...

LON:AZN

Image related to an article about GSK

GSK (LON:GSK) price about to hit new 52-week high

Healthcare

The good news for any holders of GSK (LON:GSK) is that the price is currently trading close to a 52 week high, with the share price up by around 2.45% to 1,737p over the past week.  For investors holding the stock (or considering buyin...

LON:GSK

  • Quality
    76
  • Value
    83
  • Momentum
    68
  • StockRank™
    93

Unlock comprehensive stock market insights

Quickly sanity-check any investment idea, with a free trial of Stockopedia's award-winning research platform. Join over 15,000 investors who use Stockopedia to:

  • Access institutional-quality insights on thousands of stocks
  • Make more confident, successful investing decisions
  • Learn from the smartest investor community on the web
Get started for free

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"